ID   S27A2_HUMAN             Reviewed;         620 AA.
AC   O14975; A8K2J7; Q53FY6; Q6PF09;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 2.
DT   28-JUN-2023, entry version 185.
DE   RecName: Full=Long-chain fatty acid transport protein 2 {ECO:0000305};
DE   AltName: Full=Arachidonate--CoA ligase;
DE            EC=6.2.1.15 {ECO:0000250|UniProtKB:O35488};
DE   AltName: Full=Fatty acid transport protein 2 {ECO:0000303|PubMed:20530735};
DE            Short=FATP-2 {ECO:0000303|PubMed:20530735};
DE   AltName: Full=Fatty-acid-coenzyme A ligase, very long-chain 1;
DE   AltName: Full=Long-chain-fatty-acid--CoA ligase;
DE            EC=6.2.1.3 {ECO:0000269|PubMed:10198260, ECO:0000269|PubMed:10749848, ECO:0000269|PubMed:11980911};
DE   AltName: Full=Phytanate--CoA ligase;
DE            EC=6.2.1.24 {ECO:0000269|PubMed:10198260};
DE   AltName: Full=Solute carrier family 27 member 2;
DE   AltName: Full=THCA-CoA ligase;
DE            EC=6.2.1.7 {ECO:0000269|PubMed:11980911};
DE   AltName: Full=Very long-chain acyl-CoA synthetase {ECO:0000303|PubMed:10198260, ECO:0000303|PubMed:10749848, ECO:0000303|PubMed:11980911};
DE            Short=VLACS {ECO:0000303|PubMed:20530735};
DE            Short=VLCS {ECO:0000303|PubMed:10198260, ECO:0000303|PubMed:10749848, ECO:0000303|PubMed:11980911};
DE            EC=6.2.1.- {ECO:0000269|PubMed:10198260, ECO:0000269|PubMed:10749848, ECO:0000269|PubMed:11980911, ECO:0000269|PubMed:21768100};
DE   AltName: Full=Very long-chain-fatty-acid-CoA ligase;
GN   Name=SLC27A2; Synonyms=ACSVL1, FACVL1, FATP2, VLACS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLN-48.
RC   TISSUE=Liver;
RA   Uchiyama A., Aoyama T., Kamijo K., Wakui K., Fukushima Y., Shimozawa N.,
RA   Suzuki Y., Kondo N., Orii T., Hashimoto T.;
RT   "Molecular cloning of a possible human homolog of the rat very-long-chain
RT   acyl-CoA synthetase cDNA and its chromosomal localization.";
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, FUNCTION, CATALYTIC ACTIVITY, AND VARIANT GLN-48.
RX   PubMed=10198260; DOI=10.1006/bbrc.1999.0510;
RA   Steinberg S.J., Wang S.J., Kim D.G., Mihalik S.J., Watkins P.A.;
RT   "Human very-long-chain acyl-CoA synthetase: cloning, topography, and
RT   relevance to branched-chain fatty acid metabolism.";
RL   Biochem. Biophys. Res. Commun. 257:615-621(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLN-48.
RC   TISSUE=Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLN-48.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=10640429; DOI=10.1006/excr.1999.4757;
RA   Smith B.T., Sengupta T.K., Singh I.;
RT   "Intraperoxisomal localization of very-long-chain fatty acyl-CoA
RT   synthetase: implication in X-adrenoleukodystrophy.";
RL   Exp. Cell Res. 254:309-320(2000).
RN   [9]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=10749848; DOI=10.1074/jbc.c000015200;
RA   Steinberg S.J., Mihalik S.J., Kim D.G., Cuebas D.A., Watkins P.A.;
RT   "The human liver-specific homolog of very long-chain acyl-CoA synthetase is
RT   cholate:CoA ligase.";
RL   J. Biol. Chem. 275:15605-15608(2000).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, TOPOLOGY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11980911; DOI=10.1074/jbc.m203295200;
RA   Mihalik S.J., Steinberg S.J., Pei Z., Park J., Kim do G., Heinzer A.K.,
RA   Dacremont G., Wanders R.J., Cuebas D.A., Smith K.D., Watkins P.A.;
RT   "Participation of two members of the very long-chain acyl-CoA synthetase
RT   family in bile acid synthesis and recycling.";
RL   J. Biol. Chem. 277:24771-24779(2002).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, TRANSPORT ACTIVITY, TISSUE SPECIFICITY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=20530735; DOI=10.1152/ajpendo.00226.2010;
RA   Falcon A., Doege H., Fluitt A., Tsang B., Watson N., Kay M.A., Stahl A.;
RT   "FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain
RT   acyl-CoA synthetase.";
RL   Am. J. Physiol. 299:E384-393(2010).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-577, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   FUNCTION, CATALYTIC ACTIVITY, TRANSPORT ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=22022213; DOI=10.7150/ijms.8.599;
RA   Krammer J., Digel M., Ehehalt F., Stremmel W., Fuellekrug J., Ehehalt R.;
RT   "Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1
RT   increases fatty acid uptake in human hepatoma cells.";
RL   Int. J. Med. Sci. 8:599-614(2011).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   FUNCTION (ISOFORMS 1 AND 2), CATALYTIC ACTIVITY (ISOFORMS 1 AND 2), TISSUE
RP   SPECIFICITY (ISOFORMS 1 AND 2), AND TRANSPORT ACTIVITY (ISOFORMS 1 AND 2).
RX   PubMed=21768100; DOI=10.1074/jbc.m111.226316;
RA   Melton E.M., Cerny R.L., Watkins P.A., DiRusso C.C., Black P.N.;
RT   "Human fatty acid transport protein 2a/very long chain acyl-CoA synthetase
RT   1 (FATP2a/Acsvl1) has a preference in mediating the channeling of exogenous
RT   n-3 fatty acids into phosphatidylinositol.";
RL   J. Biol. Chem. 286:30670-30679(2011).
RN   [17]
RP   CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=24269233; DOI=10.1016/j.bbrc.2013.11.036;
RA   Ohkuni A., Ohno Y., Kihara A.;
RT   "Identification of acyl-CoA synthetases involved in the mammalian
RT   sphingosine 1-phosphate metabolic pathway.";
RL   Biochem. Biophys. Res. Commun. 442:195-201(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-577, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Mediates the import of long-chain fatty acids (LCFA) into the
CC       cell by facilitating their transport across cell membranes, playing an
CC       important role in hepatic fatty acid uptake (PubMed:20530735,
CC       PubMed:22022213, PubMed:24269233, PubMed:10198260, PubMed:10749848,
CC       PubMed:11980911). Also functions as an acyl-CoA ligase catalyzing the
CC       ATP-dependent formation of fatty acyl-CoA using LCFA and very-long-
CC       chain fatty acids (VLCFA) as substrates, which prevents fatty acid
CC       efflux from cells and might drive more fatty acid uptake
CC       (PubMed:20530735, PubMed:22022213, PubMed:24269233, PubMed:10198260,
CC       PubMed:10749848, PubMed:11980911). Plays a pivotal role in regulating
CC       available LCFA substrates from exogenous sources in tissues undergoing
CC       high levels of beta-oxidation or triglyceride synthesis
CC       (PubMed:20530735). Can also activate branched-chain fatty acids such as
CC       phytanic acid and pristanic acid (PubMed:10198260). May contribute to
CC       the synthesis of sphingosine-1-phosphate (PubMed:24269233). Does not
CC       activate C24 bile acids, cholate and chenodeoxycholate
CC       (PubMed:11980911). In vitro, activates 3-alpha,7-alpha,12-alpha-
CC       trihydroxy-5-beta-cholestanate (THCA), the C27 precursor of cholic acid
CC       deriving from the de novo synthesis from cholesterol (PubMed:11980911).
CC       However, it is not critical for THCA activation and bile synthesis in
CC       vivo (PubMed:20530735). {ECO:0000269|PubMed:10198260,
CC       ECO:0000269|PubMed:10749848, ECO:0000269|PubMed:11980911,
CC       ECO:0000269|PubMed:20530735, ECO:0000269|PubMed:22022213,
CC       ECO:0000269|PubMed:24269233}.
CC   -!- FUNCTION: [Isoform 1]: Exhibits both long-chain fatty acids (LCFA)
CC       transport activity and acyl CoA synthetase towards very long-chain
CC       fatty acids (PubMed:21768100, PubMed:10198260). Shows a preference for
CC       generating CoA derivatives of n-3 fatty acids, which are preferentially
CC       trafficked into phosphatidylinositol (PubMed:21768100).
CC       {ECO:0000269|PubMed:10198260, ECO:0000269|PubMed:21768100}.
CC   -!- FUNCTION: [Isoform 2]: Exhibits long-chain fatty acids (LCFA) transport
CC       activity but lacks acyl CoA synthetase towards very long-chain fatty
CC       acids. {ECO:0000269|PubMed:21768100}.
CC   -!- CATALYTIC ACTIVITY: [Isoform 1]:
CC       Reaction=a fatty acid(in) = a fatty acid(out); Xref=Rhea:RHEA:38879,
CC         ChEBI:CHEBI:28868; Evidence={ECO:0000269|PubMed:20530735,
CC         ECO:0000269|PubMed:21768100, ECO:0000269|PubMed:22022213};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:38881;
CC         Evidence={ECO:0000305|PubMed:20530735, ECO:0000305|PubMed:21768100};
CC   -!- CATALYTIC ACTIVITY: [Isoform 1]:
CC       Reaction=(9Z)-octadecenoate(out) = (9Z)-octadecenoate(in);
CC         Xref=Rhea:RHEA:33655, ChEBI:CHEBI:30823;
CC         Evidence={ECO:0000269|PubMed:22022213};
CC   -!- CATALYTIC ACTIVITY: [Isoform 2]:
CC       Reaction=a fatty acid(in) = a fatty acid(out); Xref=Rhea:RHEA:38879,
CC         ChEBI:CHEBI:28868; Evidence={ECO:0000269|PubMed:21768100};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:38881;
CC         Evidence={ECO:0000305|PubMed:21768100};
CC   -!- CATALYTIC ACTIVITY: [Isoform 1]:
CC       Reaction=a long-chain fatty acid + ATP + CoA = a long-chain fatty acyl-
CC         CoA + AMP + diphosphate; Xref=Rhea:RHEA:15421, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57560,
CC         ChEBI:CHEBI:83139, ChEBI:CHEBI:456215; EC=6.2.1.3;
CC         Evidence={ECO:0000269|PubMed:10198260, ECO:0000269|PubMed:10749848,
CC         ECO:0000269|PubMed:11980911, ECO:0000269|PubMed:22022213,
CC         ECO:0000305|PubMed:20530735};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15422;
CC         Evidence={ECO:0000305|PubMed:10198260, ECO:0000305|PubMed:10749848,
CC         ECO:0000305|PubMed:11980911, ECO:0000305|PubMed:20530735,
CC         ECO:0000305|PubMed:22022213};
CC   -!- CATALYTIC ACTIVITY: [Isoform 1]:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + ATP + CoA =
CC         (5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:19713, ChEBI:CHEBI:30616, ChEBI:CHEBI:32395,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:456215; EC=6.2.1.15;
CC         Evidence={ECO:0000250|UniProtKB:O35488};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19714;
CC         Evidence={ECO:0000250|UniProtKB:O35488};
CC   -!- CATALYTIC ACTIVITY: [Isoform 1]:
CC       Reaction=ATP + CoA + hexadecanoate = AMP + diphosphate + hexadecanoyl-
CC         CoA; Xref=Rhea:RHEA:30751, ChEBI:CHEBI:7896, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:10198260,
CC         ECO:0000269|PubMed:10749848, ECO:0000269|PubMed:11980911,
CC         ECO:0000305|PubMed:20530735};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:30752;
CC         Evidence={ECO:0000305|PubMed:10198260, ECO:0000305|PubMed:10749848,
CC         ECO:0000305|PubMed:11980911, ECO:0000305|PubMed:20530735};
CC   -!- CATALYTIC ACTIVITY: [Isoform 1]:
CC       Reaction=(9Z)-octadecenoate + ATP + CoA = (9Z)-octadecenoyl-CoA + AMP +
CC         diphosphate; Xref=Rhea:RHEA:33607, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:456215;
CC         Evidence={ECO:0000269|PubMed:22022213};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33608;
CC         Evidence={ECO:0000305|PubMed:22022213};
CC   -!- CATALYTIC ACTIVITY: [Isoform 1]:
CC       Reaction=3,7,11,15-tetramethylhexadecanoate + ATP + CoA = AMP +
CC         diphosphate + phytanoyl-CoA; Xref=Rhea:RHEA:21380, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:37257, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57391, ChEBI:CHEBI:456215; EC=6.2.1.24;
CC         Evidence={ECO:0000269|PubMed:10198260};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21381;
CC         Evidence={ECO:0000305|PubMed:10198260};
CC   -!- CATALYTIC ACTIVITY: [Isoform 1]:
CC       Reaction=(9Z,12Z,15Z)-octadecatrienoate + ATP + CoA = (9Z,12Z,15Z)-
CC         octadecatrienoyl-CoA + AMP + diphosphate; Xref=Rhea:RHEA:44936,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:32387, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:74034, ChEBI:CHEBI:456215;
CC         Evidence={ECO:0000269|PubMed:21768100};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44937;
CC         Evidence={ECO:0000305|PubMed:21768100};
CC   -!- CATALYTIC ACTIVITY: [Isoform 1]:
CC       Reaction=2,6,10,14-tetramethylpentadecanoate + ATP + CoA = AMP +
CC         diphosphate + pristanoyl-CoA; Xref=Rhea:RHEA:47264,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:77250, ChEBI:CHEBI:77268, ChEBI:CHEBI:456215;
CC         Evidence={ECO:0000269|PubMed:10198260};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47265;
CC         Evidence={ECO:0000305|PubMed:10198260};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(E)-hexadec-2-enoate + ATP + CoA = (2E)-hexadecenoyl-CoA + AMP
CC         + diphosphate; Xref=Rhea:RHEA:36139, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:61526,
CC         ChEBI:CHEBI:72745, ChEBI:CHEBI:456215;
CC         Evidence={ECO:0000269|PubMed:24269233};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36140;
CC         Evidence={ECO:0000305|PubMed:24269233};
CC   -!- CATALYTIC ACTIVITY: [Isoform 1]:
CC       Reaction=a very long-chain fatty acid + ATP + CoA = a very long-chain
CC         fatty acyl-CoA + AMP + diphosphate; Xref=Rhea:RHEA:54536,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:58950, ChEBI:CHEBI:138261, ChEBI:CHEBI:456215;
CC         Evidence={ECO:0000269|PubMed:10198260, ECO:0000269|PubMed:10749848,
CC         ECO:0000269|PubMed:11980911, ECO:0000269|PubMed:21768100,
CC         ECO:0000305|PubMed:20530735};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54537;
CC         Evidence={ECO:0000305|PubMed:10198260, ECO:0000305|PubMed:10749848,
CC         ECO:0000305|PubMed:11980911, ECO:0000305|PubMed:20530735};
CC   -!- CATALYTIC ACTIVITY: [Isoform 1]:
CC       Reaction=ATP + CoA + tetracosanoate = AMP + diphosphate +
CC         tetracosanoyl-CoA; Xref=Rhea:RHEA:33639, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:31014, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:65052, ChEBI:CHEBI:456215;
CC         Evidence={ECO:0000269|PubMed:10198260, ECO:0000269|PubMed:10749848,
CC         ECO:0000269|PubMed:21768100, ECO:0000305|PubMed:20530735};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33640;
CC         Evidence={ECO:0000305|PubMed:10198260, ECO:0000305|PubMed:10749848,
CC         ECO:0000305|PubMed:20530735, ECO:0000305|PubMed:21768100};
CC   -!- CATALYTIC ACTIVITY: [Isoform 1]:
CC       Reaction=(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate + ATP + CoA =
CC         (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:44932, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:74298, ChEBI:CHEBI:77016,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:21768100};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44933;
CC         Evidence={ECO:0000305|PubMed:21768100};
CC   -!- CATALYTIC ACTIVITY: [Isoform 1]:
CC       Reaction=(25R)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oate
CC         + ATP + CoA = (25R)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-
CC         26-oyl-CoA + AMP + diphosphate; Xref=Rhea:RHEA:22976,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:58677, ChEBI:CHEBI:58734, ChEBI:CHEBI:456215; EC=6.2.1.7;
CC         Evidence={ECO:0000269|PubMed:11980911};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22977;
CC         Evidence={ECO:0000305|PubMed:11980911};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=12 uM for hexadecanoate (palmitate) {ECO:0000269|PubMed:11980911};
CC         Vmax=1.4 nmol/min/mg enzyme for hexadecanoyl-CoA (palmitoyl-CoA)
CC         synthesis {ECO:0000269|PubMed:11980911};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:11980911, ECO:0000269|PubMed:22022213,
CC       ECO:0000269|PubMed:24269233}; Multi-pass membrane protein
CC       {ECO:0000255}. Peroxisome membrane {ECO:0000269|PubMed:10198260,
CC       ECO:0000269|PubMed:10640429}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:10640429}. Cell membrane
CC       {ECO:0000269|PubMed:20530735}; Multi-pass membrane protein
CC       {ECO:0000255}. Microsome {ECO:0000269|PubMed:10640429}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=FATP2a {ECO:0000303|PubMed:21768100};
CC         IsoId=O14975-1; Sequence=Displayed;
CC       Name=2; Synonyms=FATP2b {ECO:0000303|PubMed:21768100};
CC         IsoId=O14975-2; Sequence=VSP_042726;
CC   -!- TISSUE SPECIFICITY: [Isoform 1]: Expressed in liver, kidney, placenta,
CC       intestine, brain, heart, and colon (PubMed:10198260, PubMed:21768100,
CC       PubMed:24269233). Predominantly expressed in liver (PubMed:20530735).
CC       {ECO:0000269|PubMed:10198260, ECO:0000269|PubMed:20530735,
CC       ECO:0000269|PubMed:21768100, ECO:0000269|PubMed:24269233}.
CC   -!- TISSUE SPECIFICITY: [Isoform 2]: Expressed in liver, placenta, and
CC       intestine, but much lower relative to isoform 1.
CC       {ECO:0000269|PubMed:21768100}.
CC   -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D88308; BAA23644.1; -; mRNA.
DR   EMBL; AF096290; AAC64973.1; -; mRNA.
DR   EMBL; AK223145; BAD96865.1; -; mRNA.
DR   EMBL; AK290262; BAF82951.1; -; mRNA.
DR   EMBL; AC009753; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471082; EAW77386.1; -; Genomic_DNA.
DR   EMBL; BC057770; AAH57770.1; -; mRNA.
DR   CCDS; CCDS10133.1; -. [O14975-1]
DR   CCDS; CCDS53943.1; -. [O14975-2]
DR   RefSeq; NP_001153101.1; NM_001159629.1. [O14975-2]
DR   RefSeq; NP_003636.2; NM_003645.3. [O14975-1]
DR   AlphaFoldDB; O14975; -.
DR   SMR; O14975; -.
DR   BioGRID; 116194; 169.
DR   IntAct; O14975; 39.
DR   MINT; O14975; -.
DR   STRING; 9606.ENSP00000267842; -.
DR   BindingDB; O14975; -.
DR   ChEMBL; CHEMBL4326; -.
DR   DrugBank; DB11936; Bempedoic acid.
DR   SwissLipids; SLP:000000428; -.
DR   SwissLipids; SLP:000000431; -. [O14975-2]
DR   SwissLipids; SLP:000000432; -. [O14975-1]
DR   TCDB; 4.C.1.1.5; the fatty acid group translocation (fat) family.
DR   GlyCosmos; O14975; 2 sites, 1 glycan.
DR   GlyGen; O14975; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; O14975; -.
DR   MetOSite; O14975; -.
DR   PhosphoSitePlus; O14975; -.
DR   SwissPalm; O14975; -.
DR   BioMuta; SLC27A2; -.
DR   EPD; O14975; -.
DR   jPOST; O14975; -.
DR   MassIVE; O14975; -.
DR   MaxQB; O14975; -.
DR   PaxDb; O14975; -.
DR   PeptideAtlas; O14975; -.
DR   ProteomicsDB; 48348; -. [O14975-1]
DR   ProteomicsDB; 48349; -. [O14975-2]
DR   Antibodypedia; 12170; 209 antibodies from 28 providers.
DR   DNASU; 11001; -.
DR   Ensembl; ENST00000267842.10; ENSP00000267842.5; ENSG00000140284.11. [O14975-1]
DR   Ensembl; ENST00000380902.8; ENSP00000370289.4; ENSG00000140284.11. [O14975-2]
DR   GeneID; 11001; -.
DR   KEGG; hsa:11001; -.
DR   MANE-Select; ENST00000267842.10; ENSP00000267842.5; NM_003645.4; NP_003636.2.
DR   UCSC; uc001zxw.4; human. [O14975-1]
DR   AGR; HGNC:10996; -.
DR   CTD; 11001; -.
DR   DisGeNET; 11001; -.
DR   GeneCards; SLC27A2; -.
DR   HGNC; HGNC:10996; SLC27A2.
DR   HPA; ENSG00000140284; Tissue enhanced (kidney, liver).
DR   MIM; 603247; gene.
DR   neXtProt; NX_O14975; -.
DR   OpenTargets; ENSG00000140284; -.
DR   PharmGKB; PA27971; -.
DR   VEuPathDB; HostDB:ENSG00000140284; -.
DR   eggNOG; KOG1179; Eukaryota.
DR   GeneTree; ENSGT00940000161137; -.
DR   HOGENOM; CLU_000022_46_2_1; -.
DR   InParanoid; O14975; -.
DR   OMA; LQYVGEL; -.
DR   OrthoDB; 1650656at2759; -.
DR   PhylomeDB; O14975; -.
DR   TreeFam; TF313430; -.
DR   BioCyc; MetaCyc:HS06695-MON; -.
DR   PathwayCommons; O14975; -.
DR   Reactome; R-HSA-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-HSA-193775; Synthesis of bile acids and bile salts via 24-hydroxycholesterol.
DR   Reactome; R-HSA-389599; Alpha-oxidation of phytanate.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-75105; Fatty acyl-CoA biosynthesis.
DR   Reactome; R-HSA-9033241; Peroxisomal protein import.
DR   SignaLink; O14975; -.
DR   SIGNOR; O14975; -.
DR   BioGRID-ORCS; 11001; 12 hits in 1161 CRISPR screens.
DR   ChiTaRS; SLC27A2; human.
DR   GeneWiki; SLC27A2; -.
DR   GenomeRNAi; 11001; -.
DR   Pharos; O14975; Tbio.
DR   PRO; PR:O14975; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; O14975; protein.
DR   Bgee; ENSG00000140284; Expressed in bronchial epithelial cell and 160 other tissues.
DR   ExpressionAtlas; O14975; baseline and differential.
DR   Genevisible; O14975; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005778; C:peroxisomal membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0047676; F:arachidonate-CoA ligase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0047747; F:cholate-CoA ligase activity; IEA:UniProtKB-EC.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0015245; F:fatty acid transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0005324; F:long-chain fatty acid transporter activity; IDA:UniProtKB.
DR   GO; GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:UniProtKB.
DR   GO; GO:1901480; F:oleate transmembrane transporter activity; IEA:RHEA.
DR   GO; GO:0050197; F:phytanate-CoA ligase activity; IDA:UniProtKB.
DR   GO; GO:0070251; F:pristanate-CoA ligase activity; IDA:UniProtKB.
DR   GO; GO:0031957; F:very long-chain fatty acid-CoA ligase activity; IDA:UniProtKB.
DR   GO; GO:0006699; P:bile acid biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0001561; P:fatty acid alpha-oxidation; IDA:UniProtKB.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IDA:UniProtKB.
DR   GO; GO:0046949; P:fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   GO; GO:0044539; P:long-chain fatty acid import into cell; IDA:UniProtKB.
DR   GO; GO:0001676; P:long-chain fatty acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0097089; P:methyl-branched fatty acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0042760; P:very long-chain fatty acid catabolic process; IBA:GO_Central.
DR   CDD; cd05938; hsFATP2a_ACSVL_like; 1.
DR   Gene3D; 3.30.300.30; -; 1.
DR   Gene3D; 3.40.50.12780; N-terminal domain of ligase-like; 1.
DR   InterPro; IPR025110; AMP-bd_C.
DR   InterPro; IPR045851; AMP-bd_C_sf.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig_com.
DR   InterPro; IPR042099; ANL_N_sf.
DR   PANTHER; PTHR43107; LONG-CHAIN FATTY ACID TRANSPORT PROTEIN; 1.
DR   PANTHER; PTHR43107:SF13; VERY LONG-CHAIN ACYL-COA SYNTHETASE; 1.
DR   Pfam; PF00501; AMP-binding; 1.
DR   Pfam; PF13193; AMP-binding_C; 1.
DR   SUPFAM; SSF56801; Acetyl-CoA synthetase-like; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Cell membrane;
KW   Endoplasmic reticulum; Fatty acid metabolism; Ligase; Lipid metabolism;
KW   Lipid transport; Membrane; Microsome; Nucleotide-binding; Peroxisome;
KW   Phosphoprotein; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..620
FT                   /note="Long-chain fatty acid transport protein 2"
FT                   /id="PRO_0000193204"
FT   TOPO_DOM        1..4
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305|PubMed:11980911"
FT   TRANSMEM        5..27
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        28..106
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:11980911"
FT   TRANSMEM        107..127
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        128..261
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305|PubMed:11980911"
FT   TRANSMEM        262..282
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        283..620
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:11980911"
FT   BINDING         222..233
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         291
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O35488"
FT   MOD_RES         577
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         230..282
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_042726"
FT   VARIANT         48
FT                   /note="K -> Q (in dbSNP:rs1648348)"
FT                   /evidence="ECO:0000269|PubMed:10198260,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|Ref.1,
FT                   ECO:0000269|Ref.6"
FT                   /id="VAR_046533"
SQ   SEQUENCE   620 AA;  70312 MW;  752E2FFBB2E47C26 CRC64;
     MLSAIYTVLA GLLFLPLLVN LCCPYFFQDI GYFLKVAAVG RRVRSYGKRR PARTILRAFL
     EKARQTPHKP FLLFRDETLT YAQVDRRSNQ VARALHDHLG LRQGDCVALL MGNEPAYVWL
     WLGLVKLGCA MACLNYNIRA KSLLHCFQCC GAKVLLVSPE LQAAVEEILP SLKKDDVSIY
     YVSRTSNTDG IDSFLDKVDE VSTEPIPESW RSEVTFSTPA LYIYTSGTTG LPKAAMITHQ
     RIWYGTGLTF VSGLKADDVI YITLPFYHSA ALLIGIHGCI VAGATLALRT KFSASQFWDD
     CRKYNVTVIQ YIGELLRYLC NSPQKPNDRD HKVRLALGNG LRGDVWRQFV KRFGDICIYE
     FYAATEGNIG FMNYARKVGA VGRVNYLQKK IITYDLIKYD VEKDEPVRDE NGYCVRVPKG
     EVGLLVCKIT QLTPFNGYAG AKAQTEKKKL RDVFKKGDLY FNSGDLLMVD HENFIYFHDR
     VGDTFRWKGE NVATTEVADT VGLVDFVQEV NVYGVHVPDH EGRIGMASIK MKENHEFDGK
     KLFQHIADYL PSYARPRFLR IQDTIEITGT FKHRKMTLVE EGFNPAVIKD ALYFLDDTAK
     MYVPMTEDIY NAISAKTLKL
//
